January 31, 2007
Zyprexa Sales Up, Cymbalta Sales Way Up
Eli Lilly today released its financials for all of 2006. Zyprexa sales totaled $4.363 billion up from $4.2 billion in 2005. Cymbalta, the company's newish SNRI anti-depressant, had sales of $1.316 billion, way up from 2005 sales of $679 million. That's a 94 percent increase in the drug's second full year on the market.
In other news, in 2006 this site experienced a 94 percent increase in comments about Cymbalta. Most of them were negative.
Posted by Philip Dawdy at January 31, 2007 10:28 AM
del.icio.us
Digg it
reddit
Philip~
Thank you for covering these critical issues. May your readership grow!
Best,
Moira
The target numbers for Cymbalta are staggering. It will be a 4 billion dollar a year drug by 2009. Especially once it is approved for GAD and Fibromyalgia by the FDA (in the works, sNDA's are in already).
Re: Cymbalta
2006 sales = $1,316,000,000
2005 sales = $679,000,000
= 48.4% increase from 2005 to 2006
